IDH1 and acute myeloid leukemia: Mechanistic investigations into the model of action of IDH mutations have shown that hematopoietic specific IDH1 (R132H) mutation using a conditional knock-in strategy expands HSC and myeloid progenitor compartments but fail to show signs of overt AML (40).